Most importantly, the GABA catabolic enzyme GAD (glutamate decarboxylase) inhibitor 3-mercaplopropionic acid (3-MPA) significantly suppressed breast cancer cell migration (Figure 2H). The gene discussed is GLUL; the disease is breast carcinoma.